PATENT CLAIM ANALYSIS

Application Number: 15772910
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["540", "467000"]

Abstract:
The present invention provides compositions and methods for providing controllable local delivery of a conjugate of bortezomib (Btz) and a bisphosphonate to promote bone formation. In certain embodiments, the invention is used as a treatment for a subject with diseases and disorders characterized by bone loss.

Claim (Index 12):
The compound of  claim 1 , wherein Z 5  is

Metadata:
- Claim Count in Document: 33.0
- Percentile: 93.0
- Lexical Diversity: 1.2439
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15772893', '15094733', '14378089', '10576228', '15951585']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7140818483175994
- 35 USC 102 Novelty (BERT): 0.536451878768914
- Combined Prediction Score: 0.6963188513627309
- Mean Citation Score: 295.387648
- Max Citation Score: 362.4084
- Similarity Product: 290.68862109003067

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test